RE:I figured this would be the case Good points. Unfortunately bashers are still trying to read the sedar report. Not likely to be sensible and take away any positives. Hope this jumps up tomorrow and people keep thier wits about them. If not though I'll hold thier panic sold shares for them lol.
Wasteoftime12 wrote: I figured this would be the case with the labs. Is what it is. Next quarter full Q of Birdhouse. California and Nevada facilities. Panic buying is causing people to hoard and stock pile weed. Been mentioned multiple times, concentrates selling out. Production is now 24/7. Resulting in lower costs. But logic dictates if products are being made 24/7 they are selling out. That's what I read into it, on the positive side, they are agile and flexible. Not big revenues because of the issues with the lab. So no bulk sales from extracts. But if their products have increased demand. And production 24/7 perhaps the strategy has shifted to making sure enough product to support demand. If the THC lab went ahead and there were issues you wouldn't be able to fulfill demand, thus harming the brand and brand growth. MedMen sells 1933 white label, and just received some of tranche 4 and the float has decreased significantly. Their new stores are on hold as well. As is construction in my city. If it doesn't need to be done now it isn't being done because of social distancing. I highly doubt Paul Rosen and Tony Hawk are going to throw 9 million dollars away. Bad disease right now so it is what it is. Moving forward risks another raise and dilution. Our float and outstanding shares isn't a crazy number. So next quarter 2 facilities running. Demand from hoarding. Manufacturing is 24/7 to meet increases demand. Essential business. White label supplier. Running 24 hours a day. Increased demand is the take away here folks.